Controlled release of liposomes from biodegradable dextran microspheres: A novel delivery concept

Pharmaceutical Research

Volumn 17, Issue 6, 2000, Pages 690-695

  Stenekes, R J H ^a   Loebis, A E ^a   Fernandes, C M ^a   Crommelin, D J A ^a   Hennink, W E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Controlled release; Dextran; Hydrogel; Liposomes; Microspheres

Indexed keywords

CALCEIN; CHLOROFORM; CHOLESTEROL; DEXTRAN 40; DEXTRAN DERIVATIVE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; ETHYLENEDIAMINE DERIVATIVE; LIPOSOME; MACROGOL 10000; METHACRYLIC ACID; METHANOL; MICROSPHERE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; POTASSIUM DERIVATIVE; TRITON X 100;

ARTICLE; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG DEGRADATION; DRUG STABILITY; HYDROGEL; MEMBRANE FLUIDITY; MICROENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; SPHERONIZATION; SUSTAINED DRUG RELEASE; WATER CONTENT;

CALORIMETRY, DIFFERENTIAL SCANNING; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MEMBRANE FLUIDITY; MICROSCOPY, FLUORESCENCE; MICROSPHERES;

EID: 0033840156     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Liposomes: Quo vadis?
2. Liposome circulation time and tumor targeting: Implications for cancer chemotherapy
3. Interleukin-2-containing liposomes: Interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines
4. The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: Entrapment efficiency and ultracentrifugation data
5. Pharmacokinetic study of liposome-encapsulated human interferon-gamma after intravenous and intramuscular injection in mice
6. Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines
7. Kinetics and prophylactic efficacy of increasing dosages of liposome encapsulated chloroquine after intramuscular injection in mice
8. Biodegradable hydrogels in drug delivery
9. Controlled release of proteins from dextran hydrogels
10. Degradation and release behavior of dextran-based hydrogels
11. Delayed release of a model protein from enzymatically-degrading dextran hydrogels
12. Controlled release of a model protein from enzymatically degrading dextran microspheres
13. Degradable dextran hydrogels: Controlled release of a model protein from cylinders and microspheres
14. In vivo biocompatibility of dextran-based hydrogels
15. A novel preparation method for polymeric microparticles without the use of organic solvents
16. The preparation of dextran microspheres in an all-aqueous system: Effect of the formulation parameters on particle characteristics
17. Stability of protein pharmaceuticals
18. Liposome-collagen gel matrix: A novel sustained drug delivery system
19. The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes
20. Enzymatically activated microencapsulated liposomes can provide pulsatile drug release
21. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection
22. Reaction of dextran with glycidyl methacrylate: An unexpected transesterification
23. A new class of polymerizable dextran with hydrolyzable groups: Hydroxyethyl methacrylated dextran with and without oligolactate spacer
24. Synthesis, characterization of 2-(methacryloyloxy)ethyl-(di-)L-lactate and their application in dextran-based hydrogels
25. Calcein as a tool in liposome methodology
26. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorous analysis of spots
27. Equilibrium water content of microspheres based on cross-linked dextran
28. Stability of liposomes on storage: Freeze dried, frozen or as an aqueous dispersion
29. Degradation kinetics of methacrylated dextrans in aqueous solution
30. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches